Unraveling APOE4: The dual role in CNS and peripheral inflammation in Alzheimer's disease
- 15 July 2025
- journal article
- review article
- Published by Elsevier in International Immunopharmacology
- Vol. 163, 115199
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82072531)
This publication has 207 references indexed in Scilit:
- Silencing Apoe with divalent‐siRNAs improves amyloid burden and activates immune response pathways in Alzheimer's diseaseAlzheimer's & Dementia, 2024
- ApoE4 and Connectivity-Mediated Spreading of Tau Pathology at Lower Amyloid LevelsJAMA Neurology, 2023
- Tryptamine: A privileged scaffold for the management of Alzheimer's diseaseDrug Development Research, 2023
- APOE and immunity: Research highlightsAlzheimer's & Dementia, 2023
- Effects of risk factors on longitudinal changes in brain structure and function in the progression of ADAlzheimer's & Dementia, 2023
- Expression and secretion of apoE isoforms in astrocytes and microglia during inflammationGlia, 2021
- Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-βJAMA Neurology, 2020
- Transcriptional regulation of APP by apoE: To boldly go where no isoform has gone beforeBioEssays, 2017
- Amyloid‐β efflux from the central nervous system into the plasmaAnnals of Neurology, 2014
- Human and Murine ApoE Markedly Alters Aβ Metabolism before and after Plaque Formation in a Mouse Model of Alzheimer's DiseaseNeurobiology of Disease, 2002